Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels.

• मुख्य लेखकों: Kathrin Arndts (लेखक), Sabine Specht (लेखक), Alexander Y Debrah (लेखक), Francesca Tamarozzi (लेखक), Ute Klarmann Schulz (लेखक), Sabine Mand (लेखक), Linda Batsa (लेखक), Alexander Kwarteng (लेखक), Mark Taylor (लेखक), Ohene Adjei (लेखक), Coralie Martin (लेखक), Laura E Layland (लेखक), Achim Hoerauf (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Public Library of Science (PLoS), 2014-02-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Mass drug administration (MDA) programmes against Onchocerca volvulus use ivermectin (IVM) which targets microfilariae (MF), the worm's offspring. Most infected individuals are hyporesponsive and present regulated immune responses despite high parasite burden. Recently, with MDA programmes, the...